Donna M Gitter

Education

J.D., Law, University of Pennsylvania Law School

B.A., Government, Cornell University College of Arts and Sciences, Phi Beta Kappa and cum laude

Journal Articles

Gitter, D. (2010). The Challenges of Achieving Open Source Sharing of Biobank Data. 29. 623-635.

Gitter, D. (2008). Resolving the Open Source Paradox in Biotechnology: A Proposal for a Revised Open Source Policy for Publicly Funded Genomic Databases. 24. 529-539.

Gitter, D. (2002). IP Holder Gains Edge in E.U. Competition Action. National Law Journal, B14-15.

Book Chapters

Gitter, D. (2018). Big Data and Informed Consent: The Case of Estimated Data. Big Data, Health Law, and Bioethics Cambridge University Press.

Gitter, D. (2013). The Challenges of Achieving Open Source Sharing of Biobank Data (invited contribution). In Pascuzzi, G., Izzo, U., & Macilotti, M. (Eds.), Comparative Issues in the Governance of Research Biobanks: Property, Privacy, Intellectual Property, and the Role of Technology (pp. 165-189). Springer.

(2013). Biopharmaceuticals Under the Patient Protection and Affordable Care Act: Determining the Appropriate Market and Data Exclusivity Periods. The Changing Face of US Patent Law and Its Impact on Business Strategy (pp. 211-230). Edward Elgar Publishing.

Gitter, D. (2012). The 1000 Genomes Project (invited contribution). In Rimmer, D., & McLennan, A. (Eds.), Intellectual Property and Emerging Technologies in Biotechnology (pp. 158-175). Edward Elgar Publishing Ltd..

Gitter, D. (2012). French Criminalization of Racial Employment Discrimination Compared to the Imposition of Civil Penalties in the United States (invited to reprint my earlier work). In Harris, P. P. (Ed.), Race and equality law Ashgate Publishing Group.

Law Reviews

Gitter, D. M. (2023). Achieving Genetic Data Privacy Through Enforcement of Property Rights UC Davis Law Review.

Gitter, D. M. (2022). First Amendment Challenges to State Vaccine Mandates: Why the U.S. Supreme Court Should Hold That the Free Exercise Clause Does Not Require Religious Exemptions (No.6). American University Law Reveiw.

Gitter, D. M. (2019). The Ethics of Big Data in Genomics: The Instructive Icelandic Saga of the Incidentalome (No.2). Washington University Global Studies Law Review.

Gitter, D. (2017). Informed Consent and Privacy of Non-identified Biospecimens and Estimated Data: Lessons from Iceland and the United States in an Era of Computational Genomics (No.4). Cardozo Law Review.

Gitter, D. (2013). Biopharmaceuticals Under the Patient Protection and Affordable Care Act: Determining the Appropriate Market and Data Exclusivity Periods Texas Intellectual Property Law Journal.

Gitter, D. (2011). Informed by the European Union Experience: What the United States Can Anticipate and Learn from the European Union's Regulatory Approach to Biosimilars Seton Hall Law Review (invited contribution to symposium issue).

Gitter, D. (2011). The Application of Data Access Policies Designed for Genome-Wide Association Studies to Smaller Scale Databases The John Marshall Review of Intellectual Property Law (invited contribution to symposium issue).

Gitter, D. (2009). Should the United States Designate Specialist Patent Trial Judges? An Empirical Analysis of H.R. 628 in Light of the U.K. Experience and the Work of Professor Moore Columbia Science and Technology Law Review.

Gitter, D. (2008). Innovators and Imitators: An Analysis of Proposed Legislation Implementing an Abbreviated Approval Pathway for Follow-on Biologics in the United States Florida State University Law Review (lead article) .

Gitter, D. (2007). Resolving the Open Source Paradox in Biotechnology: A Proposal for a Revised Open Source Policy for Publicly Funded Genomic Databases Houston Law Review.

Gitter, D. (2006). Am I My Brother's Keeper? The Use of Preimplantation Genetic Diagnosis to Create a Donor of Transplantable Stem Cells for an Older Sibling Suffering from a Genetic Disorder George Mason Law Review (lead article).

Gitter, D. (2004). Ownership of Human Tissue: A Proposal for Federal Recognition of Human Research Participants' Property Rights in Their Biological Material Washington and Lee Law Review.

Gitter, D. (2004). Strong Medicine for Competition Ills: The Judgment of the European Court of Justice in the IMS Health Action and Its Implications for Microsoft Corporation Duke Journal For Comparative and International Law.

Gitter, D. (2003). The Conflict in the European Community Between Competition Law and Intellectual Property Rights: A Call for Legislative Clarification of the Essential Facilities Doctrine American Business Law Journal (lead article in, and award recipient from, refereed scholarly journal).

Gitter, D. (2001). Led Astray by the Moral Compass: Incorporating Morality into European Union Biotechnology Patent Law Berkeley Journal of International Law (lead article).

Gitter, D. (2001). International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption New York University Law Review (lead article).

Gitter, D. (1994). French Criminalization of Racial Employment Discrimination Compared to the Imposition of Civil Penalties in the United States Comparative Labor Law Journal.

Media Contributions

Gitter, D. M. (2022). The Supreme Court Threatens to Undermine Vaccination Decisions Entrusted to the States, Harvard Law School Bill of Health, (Oct. 27, 2022).

Gitter, D. M. (2017). Bloomberg Business.

(2009). Law 360.

Presentations

Gitter, D. M. First Amendment Challenges to State Vaccine Mandates: Why the U.S. Supreme Court Should Hold That the Free Exercise Clause Does Not Require Religious Exemptions. Second Annual Cross-College Faculty Research Symposium. : Baruch College.

Gitter, D. M. (2024, November 6). Offering Students Authentic Writing Assignments by Partnering With Nonprofit Organizations. Experiential Learning at CUNY Virtual Conference: Perspectives and Possibilities. Virtual: CUNY. In Progress.

Gitter, D. (2018, August 2). Startup Law and Incorporation; Patents and Intellectual Property. Baruch Leadership Academy Summer 2018. : Baruch College.

Gitter, D. (2018, September 7). The Ethics of Big Data in Genomics: The Instructive Icelandic Saga of the Incidentalome. Wiet Life Science Law Scholars Conference. Chicago, IL: Loyola University Chicago School of Law.

Gitter, D. (2018, October 12). The Ethics of Big Data in Genomics: The Instructive Icelandic Saga of the Incidentalome. Second Annual Symposium on Data Analytics. New York, NY: Paul H. Chook Department of Information Systems and Statistics, Baruch College, Zicklin School of Business.

Gitter, D. (2018, November 2). The Ethics of Big Data in Genomics: The Instructive Icelandic Saga of the Incidentalome. Normative Business Ethics Workshop of the Carol and Lawrence Zicklin Center for Business Ethics Research. Philadelphia: Wharton School, University of Pennsylvania.

Gitter, D. (2017, April 30). The Net Economic Benefit Exemption Under U.S. and Phillppine Competition Law. Manila, Philippines: Ateneo Law School, Philippines/Intellectual Property Office of the Philippines.

Gitter, D. (2017, April 30). Bioethics and Intellectual Property Law for Innovators. Manila, Philippines: University of the Philippines/Intellectual Property Association of the Philippines.

Gitter, D. (2016, May 6). Informed Consent and Privacy of Non-identified Biospecimens and Estimated Data: Lessons from Iceland and the United States in an Era of Computational Genomics. Big Data, Health Law, and Bioethics. Boston, MA: Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School.

Gitter, D. (2016, February 22). Informed Consent and Privacy of Non-identified Biospecimens and Estimated Data: Lessons from Iceland and the United States in an Era of Computational Genomics. The Second International Conference on Big Data, Small Data, Linked Data and Open Data. Lisbon, Portugal: International Academy, Research and Industry Association (IARIA).

Gitter, D. (2015, May 7). Privacy and Informed Consent in an Era of Computational Genomics. The Biology of Genomes. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.

Gitter, D. (2015, April 18). Privacy and Informed Consent in an Era of Computational Genomics. The Law and Ethics of Big Data. Bloomington, IN: University of Indiana - Bloomington, Kelley School of Business.

Gitter, D. (2012, May 17). Biopharmaceuticals Under the Patient Protection and Affordable Care Act: Determining the Appropriate Market and Data Exclusivity Periods. Intellectual Property Law Colloquium. Ann Arbor, Michigan: University of Michigan, Ross School of Business.

Gitter, D. (2011, April 15). The Application of Data Access Policies Designed for Genome-Wide Association Studies to Smaller Scale Databases. Second Annual John Marshall Review of Intellectual Property Law Symposium. Chicago, IL: The John Marshall Law School.

Gitter, D. (2010, October 29). What the United States Can Anticipate and Learn from the European Union’s Regulatory Approach to Biosimilars. Roundtable on Follow-On Biologics in the 111th Congress: Implementation Challenges and Opportunities. Newark, New Jersey: Seton Hall University School of Law Center for Pharmaceutical Law and Policy and the Gibbons Institute of Law, Science and Technology.

Gitter, D. (2010, September 21). The Challenges of Achieving Open Source Sharing of Biobank Data. HeLEX Data Sharing Conference. Oxford, England: Centre for Health, Law and Emerging Technologies, Oxford University.

Gitter, D. (2010, May 8). The Challenges of Achieving Open Source Sharing of Biobank Data. International Conference on Comparative Issues in the Governance of Research Biobanks: Property, Privacy, Intellectual Property, and the Role of Technology. Trento, Italy: Department of Legal Sciences of the University of Trento, Italy.

Gitter, D. (2010, March 26). The Challenges of Achieving Open Source Sharing of Biobank Data. Drake University 2010 Intellectual Property Scholars Roundtable. Des Moines, Iowa: Drake University Law School, Intellectual Property Law Center.

Gitter, D. (2009, February 28). Should the United States Designate Specialist Patent Trial Judges? An Empirical Analysis of H.R. 34 in Light of the U.K. Experience and the Work of Professor Moore. Drake University 2009 Intellectual Property Scholars Roundtable. Des Moines, Iowa: Drake University Law School, Intellectual Property Law Center.

Gitter, D. (2008, June 18). Resolving the Open Source Paradox in Biotechnology: A Proposal for a Revised Open Source Policy for Publicly Funded Genomic Databases (First Runner Up for Best Academic Paper). Second Annual International Conference on Business, Law, and Technology. Touro Law School, New York: International Association of Information Technology Lawyers.

Gitter, D. (2008, September 9). Should the United States Designate Specialist Patent Trial Judges? An Empirical Analysis of H.R. 34 in Light of the U.K. Experience and the Work of Professor Moore. Department of Law Faculty Scholarship Workshop. New York, NY: Zicklin School of Business, Baruch College.

Gitter, D. (2008, September 12). Should the United States Designate Specialist Patent Trial Judges? An Empirical Analysis of H.R. 34 in Light of the U.K. Experience and the Work of Professor Moore. Third Annual Conference on Empirical Legal Studies. Ithaca, NY: Cornell University Law School.

Gitter, D. (2008, June 9). Resolving the Open Source Paradox in Biotechnology: A Proposal for a Revised Open Source Policy for Publicly Funded Genomic Databases. International Research Meeting on Open Source Biotechnology. Edinburgh, Scotland: SCRIPT Law and Technology Centre, University of Edinburgh Law School.

Gitter, D. (2007, April 17). Embryonic Stem Cell Research: Moral Questions for the 21st Century. Center for Ethics Education at Fordham University. New York, New York

Gitter, D. (2001, August 11). International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union. International Conference on Intellectual Property Rights and Legal Issues in the Post-WTO Scenario. Indian Chamber of Commerce, New Delhi, India

Gitter, D. (2001, August 4). International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union. International Conference on Legal and Managerial Strategies for Dealing with Technological Explosion in the New Millennium. Pondicherry, India: Pondicherry University.

Gitter, D. (2001, August 14). International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union. Seminar on Biotechnology Patenting. Bangalore, India: Indian Institute of Science.

Gitter, D. M. Fertile Ground for Regulation: Preserving Pre-implantation Genetic Testing While Protecting Reproductive Patients Post-Dobbs. : Baruch Law Department Faculty Research Seminar.

Research Currently in Progess

Gitter, D.(n.d.). Fertile Ground for Regulation: Preserving Pre-implantation Genetic Testing While Protecting Reproductive Patients Post-Dobbs. In Progress.

Gitter, D. M.(n.d.). Empirical Analysis of Cases Under the Illionois Biometric Privacy Act. In Progress.

College

Professional

Public